Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Frontiers in Oncology|December 5, 2022
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)Jia Li Low, Yiqing Huang, Kenneth Sooi, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9Lai-San Tham, Boon-Cher Goh, Anne Nafziger, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 9, 2005
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the ratXiaoxia Yang, Zeping Hu, Sui Yung Chan, et al.
Current Drug Metabolism|November 4, 2015
UGT1A1 Mediated Drug Interactions and its Clinical RelevanceChong Ping Goon, Ling Zhi Wang, Fang Cheng Wong, et al.
Cancers|March 6, 2020
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in CancerNatalie Yan Li Ngoi, Clarice Choong, Joanne Lee, et al.
Frontiers in Pharmacology|March 25, 2024
AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategiesMengnan Li, Limin Zhang, Jiahui Yu, et al.
British Journal of Clinical Pharmacology|March 13, 2003
Phenotyping CYP3A using midazolam in cancer and noncancer Asian patientsHow Sung Lee, Boon Cher Goh, Lu Fan, et al.
Molecules (Basel, Switzerland)|October 23, 2020
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer TherapyJiaqi Li, Jie Qing Eu, Li Ren Kong, et al.
Pharmacological Research|November 23, 2017
Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa LinnMuthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, et al.
Molecular Cancer|August 25, 2025
The application of organoids in treatment decision-making for digestive system cancers: progress and challengesYufei Wang, Limin Zhang, Louis Zizhao Wang, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Frontiers in Oncology|December 5, 2022
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)Jia Li Low, Yiqing Huang, Kenneth Sooi, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9Lai-San Tham, Boon-Cher Goh, Anne Nafziger, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 9, 2005
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the ratXiaoxia Yang, Zeping Hu, Sui Yung Chan, et al.
Current Drug Metabolism|November 4, 2015
UGT1A1 Mediated Drug Interactions and its Clinical RelevanceChong Ping Goon, Ling Zhi Wang, Fang Cheng Wong, et al.
Cancers|March 6, 2020
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in CancerNatalie Yan Li Ngoi, Clarice Choong, Joanne Lee, et al.
Frontiers in Pharmacology|March 25, 2024
AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategiesMengnan Li, Limin Zhang, Jiahui Yu, et al.
British Journal of Clinical Pharmacology|March 13, 2003
Phenotyping CYP3A using midazolam in cancer and noncancer Asian patientsHow Sung Lee, Boon Cher Goh, Lu Fan, et al.
Molecules (Basel, Switzerland)|October 23, 2020
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer TherapyJiaqi Li, Jie Qing Eu, Li Ren Kong, et al.
Pharmacological Research|November 23, 2017
Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa LinnMuthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, et al.
Molecular Cancer|August 25, 2025
The application of organoids in treatment decision-making for digestive system cancers: progress and challengesYufei Wang, Limin Zhang, Louis Zizhao Wang, et al.
Pageof 25